Weaver Consulting Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-45,600	Closed	-$40.4K	–	189
2022 Q4	$40.4K	Buy	45,600 +35,500	+351%	+$31.5K	0.02%	174
2022 Q3	$16K	Buy	+10,100	New	+$16K	0.01%	165
2020 Q4	–	Sell	-150	Closed	-$2K	–	979
2020 Q3	$2K	Buy	+150	New	+$2K	﹤0.01%	859